ATS View
한국어

Hanmi Pharm KRX:128940KOSPI

한미약품 · Korean news coverage and regulatory filings, organized.

한국어
Articles, 24h44
Articles, 7 days292
DART filings, 7 days3
Articles tracked831since Sep 11

In Q2 2026, Hanmi Pharm reported revenue of ₩467bn, up 29.3% year on year, and operating profit of ₩131bn. Hanmi Pharm (한미약품) appeared in 292 Korean news articles and 3 DART filings over the past seven days. Coverage peaked on Oct 27 with 117 articles. The most common catalyst was contracts & orders (29). It was most often mentioned alongside GC Biopharma, Dx & Vx and 글로벌테크놀로지.

Filing signals Profit +50% Revenue & profit growth Op. margin 20%+ Dividend grower Insider buying Clinical trial filing Share pledge Screener

Hanmi Pharm quarterly results consolidated, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩467bn+29.3%₩131bn
margin 28.1%		₩84.1bn
Q1 2026₩393bn+0.5%₩53.6bn
margin 13.7%		₩51.1bn
Q4 2025 derived₩433bn+23.1%₩83.3bn
margin 19.2%		₩54.1bn
Q3 2025₩362bn+0.1%₩55.1bn
margin 15.2%		₩45.4bn
Q2 2025₩361bn-4.5%₩60.4bn
margin 16.7%		₩43.0bn
Q1 2025₩391bn-3.2%₩59.0bn
margin 15.1%		₩44.7bn
Q4 2024 derived₩352bn-16.7%₩30.5bn
margin 8.7%		−₩4.8bn
Q3 2024₩362bn-0.7%₩51.0bn
margin 14.1%		₩35.0bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

Hanmi Pharm top stories 2 weeks, by number of outlets

  1. 1
    한미약품, 체중관리 제품군 확대..건기식 '에피슬림' 3종 출시
    14 outlets · 14 articlesFirst report Oct 27 08:38 한국정경신문
  2. 2
    한미약품, 3분기 누적 매출 1조2376억원
    10 outlets · 10 articlesFirst report Oct 27 16:24 메디포뉴스
  3. 3
    한미약품, 3분기 누적 매출 1조2376억···ETC 성장 견인
    9 outlets · 9 articlesFirst report Oct 27 16:21 녹색경제신문
  4. 4
    한미약품 “차세대 비만 신약 ‘잔트루타이드’로 국제 일반명 등재”
    7 outlets · 7 articlesFirst report Oct 23 17:16 이투데이
  5. 5
    녹십자·한미약품, 파브리병 신약 美 바이오마린에 최대 6300억원 기술수출
    6 outlets · 6 articlesFirst report Oct 30 06:02 이데일리Licensing dealGC Biopharma
  6. 6
    한미약품, 3분기 매출 3774억원…전년比 4.2% 증가(1보)
    6 outlets · 6 articlesFirst report Oct 27 16:11 더바이오Earnings

Latest Hanmi Pharm news Korean headlines